Data demonstrates Ronapreve reduced risk of hospitalisation in certain patients and reduced risk of symptomatic Covid-19 infections in people exposed to the virus
A final decision regarding the approval of Ronapreve is expected from the European Commission shortly
Filing marks first protein-based vaccine submitted to MHRA for authorization
Support from DFC will help produce one billion vaccine doses by the end of 2022
Key takeaways of recent quarter & conference call highlights
New safety data show a consistent benefit-risk profile across all Ocrevus clinical trials
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
The acquisition complements and strengthens Merck’s cardiovascular pipeline
The investment will increase SpeeDx internal capacity to scale up manufacturing
Subscribe To Our Newsletter & Stay Updated
